Delegates from the member boards of pharmacy adopted seven resolutions during the National Association of Boards of Pharmacy® (NABP®) 113th Annual Meeting, held May 20-23, 2017, in Orlando, FL. The resolutions addressed the following:
- Convening a task force of stakeholders, which may include Food and Drug Administration, to develop model regulations for the compounding of animal medication;
- Convening a task force to examine developing a definition of a patient-pharmacist relationship and recommend, if necessary, amending the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act);
- Collaborating with stakeholders to examine mechanisms that would allow foreign exchange students and practitioners to participate in clinical learning activities in the United States;
- Convening a task force to study long-term care pharmacy rules and to review and recommend, if necessary, amending the Model Act;
- Collaborating with state boards of pharmacy to provide guidance on defining and enforcing qualifying concurrent sister-state disciplinary actions, particularly those that involve direct patient impact or harm; and
- Reviewing existing unit-of-use packaging standards and recommend, if necessary, amending the Model Act to assist in establishing consistency for packaging unit-of-use containers.
Additionally, a recognition resolution honoring members of the Association who have passed away was approved.
The complete text of the resolutions will be available in the Publications and Reports section of the NABP website, at the end of May 2017 and will also be published in the forthcoming Special Annual Meeting Issue of Innovations.
NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions for the purpose of protecting the public health.